HSDT vs. TIVC, NUWE, NDRA, CANOQ, INM, NBSE, ATNF, PRFX, ALLR, and QLGN
Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include Tivic Health Systems (TIVC), Nuwellis (NUWE), ENDRA Life Sciences (NDRA), Cano Health (CANOQ), InMed Pharmaceuticals (INM), NeuBase Therapeutics (NBSE), 180 Life Sciences (ATNF), PainReform (PRFX), Allarity Therapeutics (ALLR), and Qualigen Therapeutics (QLGN). These companies are all part of the "medical" sector.
Tivic Health Systems (NASDAQ:TIVC) and Helius Medical Technologies (NASDAQ:HSDT) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation.
In the previous week, Helius Medical Technologies had 5 more articles in the media than Tivic Health Systems. MarketBeat recorded 11 mentions for Helius Medical Technologies and 6 mentions for Tivic Health Systems. Tivic Health Systems' average media sentiment score of 0.51 beat Helius Medical Technologies' score of 0.38 indicating that Helius Medical Technologies is being referred to more favorably in the news media.
Tivic Health Systems has a beta of 2.83, meaning that its stock price is 183% more volatile than the S&P 500. Comparatively, Helius Medical Technologies has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500.
Helius Medical Technologies received 20 more outperform votes than Tivic Health Systems when rated by MarketBeat users.
Tivic Health Systems has higher revenue and earnings than Helius Medical Technologies.
4.3% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 18.6% of Helius Medical Technologies shares are owned by institutional investors. 2.7% of Tivic Health Systems shares are owned by insiders. Comparatively, 7.3% of Helius Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Helius Medical Technologies has a consensus price target of $24.00, indicating a potential upside of 1,478.95%. Given Tivic Health Systems' higher probable upside, analysts plainly believe Helius Medical Technologies is more favorable than Tivic Health Systems.
Tivic Health Systems has a net margin of -670.99% compared to Tivic Health Systems' net margin of -1,328.14%. Helius Medical Technologies' return on equity of -182.53% beat Tivic Health Systems' return on equity.
Summary
Helius Medical Technologies beats Tivic Health Systems on 9 of the 14 factors compared between the two stocks.
Get Helius Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HSDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Helius Medical Technologies Competitors List
Related Companies and Tools
